Nivolumab,Ipilimumab,Pembrolizumab,Axitinib,Cabozantinib,Avelumab,Sunitinib,Atezolizumab,Bevacizumab,Lenvatinib
BMS,Merck,Pfizer,Exelixis,Roche,eisai
['thank you']
and thank you for highlighting the work of im resident, now applying for heme/onc fellowships! #esmo22 
Cancer researcher; Director of GU Cancers @DanaFarber; Prof of Medicine @HarvardMed; ? lover; ??@PanMass
Views are mine.